IA

IFP Advisors Portfolio holdings

AUM $3.88B
1-Year Est. Return 17.67%
This Quarter Est. Return
1 Year Est. Return
+17.67%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.88B
AUM Growth
+$361M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
5,247
New
Increased
Reduced
Closed

Top Sells

1 +$23.7M
2 +$11.7M
3 +$11M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$10M
5
ALK icon
Alaska Air
ALK
+$8.98M

Sector Composition

1 Technology 11.75%
2 Financials 4.5%
3 Consumer Discretionary 3.45%
4 Healthcare 3.3%
5 Industrials 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMPX icon
5026
Compass Therapeutics
CMPX
$941M
$21 ﹤0.01%
+6
GETY icon
5027
Getty Images
GETY
$628M
$20 ﹤0.01%
+10
ACB
5028
Aurora Cannabis
ACB
$296M
$18 ﹤0.01%
3
-15
APMU icon
5029
ActivePassive Intermediate Municipal Bond ETF
APMU
$200M
$18 ﹤0.01%
1
-364
CHGG icon
5030
Chegg
CHGG
$104M
$18 ﹤0.01%
12
-94
MDWD icon
5031
MediWound
MDWD
$242M
$18 ﹤0.01%
+1
STRO icon
5032
Sutro Biopharma
STRO
$85.3M
$18 ﹤0.01%
21
-57
AVBP icon
5033
ArriVent BioPharma
AVBP
$1B
$18 ﹤0.01%
1
CENN icon
5034
Cenntro
CENN
$13.8M
$17 ﹤0.01%
28
+6
MKTW icon
5035
MarketWise
MKTW
$39.9M
0
WKHS icon
5036
Workhorse Group
WKHS
$13.5M
$17 ﹤0.01%
15
-1
ELA icon
5037
Envela
ELA
$321M
0
LYEL icon
5038
Lyell Immunopharma
LYEL
$734M
$16 ﹤0.01%
1
-65
VTYX icon
5039
Ventyx Biosciences
VTYX
$587M
$16 ﹤0.01%
5
-44
GENVR
5040
Gen Digital Inc Contingent Value Rights
GENVR
$15 ﹤0.01%
2
AMLX icon
5041
Amylyx Pharmaceuticals
AMLX
$1.45B
$14 ﹤0.01%
+1
LVWR icon
5042
LiveWire
LVWR
$1.02B
$14 ﹤0.01%
3
LYRA icon
5043
Lyra Therapeutics
LYRA
$6.94M
$13 ﹤0.01%
2
-304
BGFV
5044
DELISTED
Big 5 Sporting Goods
BGFV
$12 ﹤0.01%
8
DEHP icon
5045
Dimensional Emerging Markets High Profitability ETF
DEHP
$301M
-32
DLHC icon
5046
DLH Holdings
DLHC
$79.3M
0
NAZ icon
5047
Nuveen Arizona Quality Municipal Income Fund
NAZ
$146M
$12 ﹤0.01%
+1
RWX icon
5048
SPDR Dow Jones International Real Estate ETF
RWX
$291M
-2,088
CTNM
5049
Contineum Therapeutics
CTNM
$344M
$12 ﹤0.01%
1
BIOA
5050
BioAge Labs
BIOA
$461M
$12 ﹤0.01%
+2